Cost or revenue: is diabetes prevention doomed due to misalignment of incentives? | Family Medicine and Community Health

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Call for Papers
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Commentary

Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Mainous 3rd AG, Yadav S, Xie Z, et al

Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?

Family Medicine and Community Health 2020;8:e000274. doi: 10.1136/fmch-2019-000274